|
Guidance on Combination Knee Products Stresses Primary Endpoints
Primary endpoints for Phase III clinical trials of combination products used to repair knee cartilage should be either improvement in physical function or reduction of pain, according to an FDA final guidance.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives